Abstract

3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL, E.C. 4.1.3.4) has a unique dual localization in both mitochondria and peroxisomes. Mitochondrial HL ( approximately 31.0 kDa) catalyzes the last step of ketogenesis; the function of peroxisomal HL ( approximately 33.5 kDa) is unknown. On density gradient fractionation, normal human lymphoblasts contain both peroxisomal and mitochondrial HL whereas in lymphoblasts from a patient with Zellweger syndrome, in which functional peroxisomes are absent, only the mitochondrial HL isoform was present. To study the kinetics of the dual targeting of HL, we performed pulse-chase experiments in normal and Zellweger cells. Pulse-chase studies revealed a biphasic curve for processing of the HL precursor. The first phase, with a calculated half-life of approximately 3 h in both normal and Zellweger fibroblasts and lymphoblasts and in HepG2 cells, presumably reflects mitochondrial import and processing of the precursor; the second (t1/2, 12-19 h) is present only in normal cells and presumably represents the half-life of peroxisomal HL. The half-life of mature mitochondrial HL was 14 to 19 h in both normal and Zellweger cells. Studies of the HMG-CoA lyase precursor in isolated rat mitochondria showed a rate of processing approximately 2.6-fold lower than that of the ornithine transcarbamylase precursor.

Highlights

  • 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL, E.C. 4.1.3.4) has a unique dual localization in both mitochondria and peroxisomes

  • In human and mouse liver, we have shown 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) lyase (HL) to be present in peroxisomes as well as in mitochondria [1]

  • In order to understand the mechanism of the dual targeting of HL to mitochondria and peroxisomes, we have compared normal cells with cells from patients with Zellweger syndrome

Read more

Summary

Cells and cell culture

Three cell types were studied: fibroblasts from normal controls and from a patient affected with Zellweger syndrome (NIGMS Human Genetic Mutant Cell Repository line GM00228A, complementation group 1), lymphoblasts from normal controls and from a Zellweger syndrome patient of complementation group 4 (a gift from Anne Moser), and human liver carcinoma (HepG2) cells. The medium was supplemented with 20% fetal calf serum and antibiotics

Fractionation of lymphoblasts
Metabolic labeling
Enzyme assays
Mitochondrial import assay
RESULTS AND DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.